Recently, miR-195-5p/FKBP1A was identified as a key factor for paclitaxel-resistant prostate cancer cells to paclitaxel via LncRNA AFAP1-AS binding to the 3ʹUTR of FKBP1A [20]. Here, FKBP1A is linked to prostate carcinoma.